6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
10m ago	Sumitomo Metal Mining : Notice regarding Dividends of Surplus for the Fiscal Year Ended March 2026
14m ago	CROSSJECT announces the successful completion of an equity financing and warrant issuance for a total immediate gross amount of €15 million
14m ago	InPost S A : Advent, FedEx, A&R and PPF launch all-cash offer for all InPost shares
14m ago	Richemont announces the end of the share buyback programme initiated in May 2023 and the launch of a new programme
14m ago	OSE Immunotherapeutics Reports Positive Topline Results of TEDOVA Phase 2 Trial with Tedopi® in Recurrent Ovarian Cancer

About

1.52USD+0.02 +1.33%

Closed • Updated at 05:44 GMT+00:00

Market Cap$189.24M

Volume1.01M

Beta3.10

RSI37.88

Gross Margin91.20%

Health TechnologyPharmaceuticals: Major

Milestone Pharmaceuticals Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Milestone Pharmaceuticals Announces First Quarter 2026 Financial Results and Provides Corporate Update

Milestone Pharmaceuticals to Announce First Quarter 2026 Financial Results on May 13, 2026

Milestone Pharmaceuticals Announces RESET-PSVT Registry to Generate Real-World Evidence on CARDAMYST™ (etripamil) Nasal Spray in Patients With PSVT

Milestone Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference

Milestone Pharmaceuticals Announces that CARDAMYST™ (etripamil) Nasal Spray is Available on Express Scripts Commercial National Formularies

Community Chat

Ask AI